<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1928-1248'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>Myeloproliferative Neoplasms (MPN) -2</span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">Myeloproliferative Neoplasms (MPN) -2: BCR-ABL Mutation Analysis by FISH and JAK2V617F Mutation Analysis by PCR </h1>
<div class="post-text">
<p>Myeloproliferative Neoplasms (MPNs) are a group of blood cancers characterized by the overproduction of blood cells in the bone marrow. The MPN-2 test involves two key genetic tests - BCR-ABL mutation analysis using Fluorescence in situ Hybridization (FISH) and JAK2V617F mutation analysis using Polymerase Chain Reaction (PCR). These tests are essential for the diagnosis and management of MPNs. </p>
<p>Myeloproliferative Neoplasms (MPNs) include various disorders characterized by an abnormal increase in blood cells produced by the bone marrow. Some common types of MPNs are Polycythemia Vera, Essential Thrombocythemia, and Chronic Myeloid Leukemia (CML). The MPN-2 test is a diagnostic tool that evaluates the presence of the BCR-ABL fusion gene through FISH and the JAK2V617F mutation through PCR. These genetic abnormalities are often found in individuals with MPNs and are important markers for diagnosis, risk stratification, and management of the disease. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">Myeloproliferative Neoplasms (MPN) -2: BCR-ABL Mutation Analysis by FISH and JAK2V617F Mutation Analysis by PCR1928-1248 </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td> Blood or Bone Marrow</td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No special preparation is required for this test. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>5 Days for FISH / 7 Days for PCR </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 9200 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is the MPN-2 test? </h2>
	<p>The MPN-2 test is a combination of two genetic tests, BCR-ABL mutation analysis by FISH and JAK2V617F mutation analysis by PCR, used for the diagnosis and management of Myeloproliferative Neoplasms. </p>
	<h2 class="test-h2 mt-3">Why is the MPN-2 test important? </h2>
	<p>The MPN-2 test is crucial in diagnosing MPNs, particularly Chronic Myeloid Leukemia which is commonly associated with the BCR-ABL fusion gene. Also, the presence of the JAK2V617F mutation is a characteristic feature in other MPNs like Polycythemia Vera and Essential Thrombocythemia. </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What does the BCR-ABL fusion gene indicate? </h2>
	<p>The BCR-ABL fusion gene is formed from the joining of parts of the BCR and ABL genes. This fusion gene produces an abnormal protein that signals the bone marrow to produce too many white blood cells, leading to Chronic Myeloid Leukemia (CML). </p>
	<h2 class="test-h2 mt-3">What does the JAK2V617F mutation indicate? </h2>
	<p>The JAK2V617F mutation is a genetic change in the JAK2 gene that results in continuous activation of JAK2, a protein involved in cell growth and division. This leads to the overproduction of blood cells, which is characteristic of certain MPNs. </p>
	<h2 class="test-h2 mt-3">How is the MPN-2 test performed? </h2>
	<p>The test requires a blood or bone marrow sample. In the lab, FISH is used to detect the BCR-ABL fusion gene by using fluorescent probes that bind to specific DNA sequences. PCR is used to amplify and analyze DNA segments, specifically the JAK2 gene, to detect the V617F mutation. </p>
	<h2 class="test-h2 mt-3">What do the results of the MPN-2 test mean? </h2>
	<p>Positive results for the BCR-ABL fusion gene are indicative of Chronic Myeloid Leukemia (CML), while a positive result for the JAK2V617F mutation suggests a diagnosis of another type of MPN such as Polycythemia Vera or Essential Thrombocythemia. </p>
	<h2 class="test-h2 mt-3">Is fasting required for the MPN-2 test? </h2>
	<p>No, fasting is not required for the MPN-2 test. </p>
	<h2 class="test-h2 mt-3">How often should I get tested? </h2>
	<p> The frequency of testing should be determined by your doctor based on your health status and any ongoing treatments.</p>
	<h2 class="test-h2 mt-3">What are the treatment options for MPNs? </h2>
	<p>Treatment options for MPNs depend on the type and severity and may include medication, blood removal, chemotherapy, or bone marrow transplantation. </p>
	<h2 class="test-h2 mt-3">Can lifestyle changes help in managing MPNs? </h2>
	<p>Yes, maintaining a healthy lifestyle, managing stress, and adhering to the treatment plan are important in managing MPNs. </p>
	<h2 class="test-h2 mt-3">Can MPNs be cured? </h2>
	<p>Currently, there is no cure for most MPNs, but treatments can help manage symptoms and reduce complications. </p>
	<h2 class="test-h2 mt-3">What should I do if the test results are abnormal? </h2>
	<p>If the MPN-2 test results are abnormal, it is important to consult your doctor for further evaluation and discussion of treatment options. </p>
	<h2 class="test-h2 mt-3">Are there risks associated with the MPN-2 test? </h2>
	<p>The risks are minimal and mainly related to the blood or bone marrow sample collection, which may cause slight pain or bruising. </p>
	<h2 class="test-h2 mt-3">Are MPNs hereditary? </h2>
	<p>Most MPNs are not inherited, but some people may have a genetic predisposition. </p>
	<h2 class="test-h2 mt-3">Can MPNs evolve into a more aggressive form of cancer? </h2>
	<p>Yes, MPNs can sometimes evolve into acute leukemia. Regular monitoring and treatment are essential to manage this risk. </p>
	
	<p>Early diagnosis and appropriate management of Myeloproliferative Neoplasms are essential for improving the patient’s quality of life and controlling the disease. The MPN-2 test, which combines BCR-ABL mutation analysis by FISH and JAK2V617F mutation analysis by PCR, is a vital tool in diagnosing and managing these disorders. If you or a loved one have been diagnosed with or are experiencing symptoms suggestive of MPN, it is crucial to discuss with your doctor the importance of the MPN-2 test. </p>
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>